Basecamp Wealth Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Basecamp Wealth Advisors's CLB Position: Q2 2026 in Review
Basecamp Wealth Advisors sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 16 shares — an estimated $269 sold.
Basecamp Wealth Advisors first reported a position in CLB in Q4 2025 and held it in 2 quarters. The position peaked at $2.68K in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Basecamp Wealth Advisors reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
- Basecamp Wealth Advisors sold 16 Core Laboratories shares in Q2 2026, an estimated $269.
- Basecamp Wealth Advisors first reported a position in Core Laboratories in Q4 2025 and held it in 2 quarters.
- Basecamp Wealth Advisors's Core Laboratories position peaked at $2.68K in Q4 2025.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.